Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study
- DOI
- 10.1016/j.lana.2024.100936
- Published
- 2024-12
- Container
- The Lancet Regional Health - Americas
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lana.2024.100936,
title = {Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study},
author = {Emanuel Krebs and Deirdre Weymann and Cheryl Ho and Ian Bosdet and Janessa Laskin and Howard J. Lim and Stephen Yip and Aly Karsan and Timothy P. Hanna and Samantha Pollard and Dean A. Regier},
year = {2024},
journal = {The Lancet Regional Health - Americas},
doi = {10.1016/j.lana.2024.100936},
url = {https://doi.org/10.1016/j.lana.2024.100936}
}RIS
TY - JOUR TI - Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study AU - Emanuel Krebs AU - Deirdre Weymann AU - Cheryl Ho AU - Ian Bosdet AU - Janessa Laskin AU - Howard J. Lim AU - Stephen Yip AU - Aly Karsan AU - Timothy P. Hanna AU - Samantha Pollard AU - Dean A. Regier PY - 2024 JO - The Lancet Regional Health - Americas DO - 10.1016/j.lana.2024.100936 UR - https://doi.org/10.1016/j.lana.2024.100936 ER -
APA
Krebs, E., Weymann, D., Ho, C., Bosdet, I., Laskin, J., Lim, H. J., Yip, S., Karsan, A., Hanna, T. P., Pollard, S., & Regier, D. A. (2024). Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study. The Lancet Regional Health - Americas. https://doi.org/10.1016/j.lana.2024.100936
Source records
- crossref · retrieved 2026-09-27T01:36:26.486Z